Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esrick

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Nature Communications|September 20, 2023
Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sicklingDaniel C De Souza, Nicolas Hebert, Erica B Esrick, et al.
Nature Medicine|November 17, 2023
Clonal selection of hematopoietic stem cells after gene therapy for sickle cell diseaseMichael Spencer Chapman, Alyssa H Cull, Marioara F Ciuculescu, et al.
Nature Medicine|March 27, 2019
Highly efficient therapeutic gene editing of human hematopoietic stem cellsYuxuan Wu, Jing Zeng, Benjamin P Roscoe, et al.
The New England Journal of Medicine|December 7, 2020
Post-Transcriptional Genetic Silencing of <i>BCL11A</i> to Treat Sickle Cell DiseaseErica B Esrick, Leslie E Lehmann, Alessandra Biffi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2023
Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell DiseaseMary Eapen, Ruta Brazauskas, David A Williams, et al.
Blood|June 3, 2026
Long-term stability of posttranscriptional genetic silencing of BCL11A using a shmiR vector in Sickle Cell DiseaseErica B Esrick, Leslie Lehmann, Amy Federico, et al.
Blood Advances|May 2, 2022
Metformin for treatment of cytopenias in children and young adults with Fanconi anemiaJessica A Pollard, Elissa Furutani, Shanshan Liu, et al.
The Lancet. Haematology|July 14, 2023
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology CommissionFrédéric B Piel, David C Rees, Michael R DeBaun, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Nature Communications|September 20, 2023
Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sicklingDaniel C De Souza, Nicolas Hebert, Erica B Esrick, et al.
Nature Medicine|November 17, 2023
Clonal selection of hematopoietic stem cells after gene therapy for sickle cell diseaseMichael Spencer Chapman, Alyssa H Cull, Marioara F Ciuculescu, et al.
Nature Medicine|March 27, 2019
Highly efficient therapeutic gene editing of human hematopoietic stem cellsYuxuan Wu, Jing Zeng, Benjamin P Roscoe, et al.
The New England Journal of Medicine|December 7, 2020
Post-Transcriptional Genetic Silencing of <i>BCL11A</i> to Treat Sickle Cell DiseaseErica B Esrick, Leslie E Lehmann, Alessandra Biffi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2023
Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell DiseaseMary Eapen, Ruta Brazauskas, David A Williams, et al.
Blood|June 3, 2026
Long-term stability of posttranscriptional genetic silencing of BCL11A using a shmiR vector in Sickle Cell DiseaseErica B Esrick, Leslie Lehmann, Amy Federico, et al.
Blood Advances|May 2, 2022
Metformin for treatment of cytopenias in children and young adults with Fanconi anemiaJessica A Pollard, Elissa Furutani, Shanshan Liu, et al.
The Lancet. Haematology|July 14, 2023
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology CommissionFrédéric B Piel, David C Rees, Michael R DeBaun, et al.
Pageof 4